Post Profile

See more about: Regeneron Pharmaceuticals

Related Posts

Regeneron Pharmaceuticals Inc (REGN): Is This Momentum Stock’s Rally Over?

Business & Finance / Investing : Insider Monkey

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) peaked on May 14 with a price of $283.99, and has since pulled back to its current price of $260. The drugmaker has been one of the best-performing stocks of the last few years, trading hi...

Biotechnology Stocks with Bullish Movements – (REGN, ACOR, SQNM, AMLN)

Business & Finance / Investing : USA Market News

Regeneron Pharmaceuticals, Inc. NASDAQ:REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) jumped +9.38% to $64.73 and its total volume during the last trading session was 1.24 million shares. Stock was opened at $59.12 and its share...

Amgen, Inc. (AMGN), Regeneron Pharmaceuticals Inc (REGN), NPS Pharmaceuticals, Inc. (NPSP): Can These Biotechs Continue to Climb?

Business & Finance / Investing : Insider Monkey

What goes up must come down. Or can it just keep going up? Two high-flying biotech stocks of late are NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Both have had great results over the past...

Will Regeneron Pharmaceuticals Inc (REGN) Earnings Grow Fast Enough for Investors?

Business & Finance / Investing : Insider Monkey

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will release its quarterly report on Tuesday, and the company’s stock has been on an absolute tear over the past year. Yet with such an aggressive valuation, Regeneron Pharmaceuticals Inc ...

Regeneron Pharmaceuticals Inc (REGN), Ampio Pharmaceuticals, Inc. (AMPE): Is This Eye Drug Worth The Hype?

Business & Finance / Investing : Insider Monkey

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) should spike– every time there’s a slight pullback the stock shoots higher. Last Thursday Regeneron gained almost 10% behind a positive Phase 3 trial for its drug Eylea. Regeneron Pharmace...


Copyright © 2016 Regator, LLC